Private Equity

Sterling Equities continually seeks investment opportunities that meet the company's strict guidelines while remaining true to our core philosophy and values.

Venture Capital

Sterling Equities invests in a diverse range completed to early-stage companies that concentrate on research and emerging technologies in the environmental and health care sectors.

Changing World Technologies (CWT), founded in August 1997, provides funding and management expertise to its wholly owned subsidiaries and joint ventures. Its purpose is to identify emerging technologies that specifically address the needs and problems in the energy and environmental arenas. CWT brings together the best technical and scientific expertise, validates the technologies, and effects the commercialization of these programs.

Renewable Environmental Solutions (RES) is the ConAgra Foods/CWT joint venture incorporated in 2000 for the deployment of its proprietary Thermal Conversion Process, or TCP. This unique technology replicates nature's geothermal processes by utilizing water, heat and pressure to reform industrial and agricultural by-products into oils, gases, specialty chemicals, carbons and fertilizer.

PathoGenesis Corporation, founded in 1991, was dedicated to the development of drugs treatments of serious human infectious diseases where there is a significant need for improved therapy. Its research and testing focus was on chronic lung infections in cystic fibrosis, tuberculosis, AIDS and multiple sclerosis; and mitigation was addressed though shortened drug discovery and development processes; screening procedures and testing.

Equity Capital

American Securities Capital Partners Fund IV, a middle market leverage buyout vehicle, is sponsored by the merchant banking arm of American Securities Capital Partners, LLC. The Fund's objective is to partner with management teams to generate long-term capital appreciation by making equity investments of $25 million to $150 million in companies with annual revenues generally ranging between $50 million and $500 million. Investments are funded from over $1 billion of committed capital which is managed on a discretionary basis.